MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CYRX made $44,233,000 in revenue. -$8,943,000 in net income. Net profit margin of -20.22%.

Income Overview

Revenue
$44,233,000
Net Income
-$8,943,000
Net Profit Margin
-20.22%
EPS
-$0.18
Unit: Dollar
Revenue Breakdown
    • Service
    • Product
Revenue Breakdown
    • Product
    • Biologistics Solutions
    • Biostorage Bioservices
Revenue Breakdown
    • Americas
    • EMEA
    • Asia Pacific

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenue
44,233,000 45,454,000 41,040,000 57,062,000
Service
12,201,000 12,449,000 --
Product
10,707,000 11,628,000 --
Total cost of revenue
22,908,000 24,077,000 22,399,000 32,534,000
Gross margin
21,325,000 21,377,000 18,641,000 24,528,000
Selling, general and administrative
26,734,000 26,908,000 24,191,000 37,680,500
Engineering and development
4,523,000 4,118,000 3,934,000 4,453,500
Impairment loss
---0
Total operating costs and expenses
31,257,000 31,026,000 28,125,000 42,134,000
Loss from operations
-9,932,000 -9,649,000 -9,484,000 -17,606,000
Investment income
3,402,000 1,466,000 1,573,000 2,013,500
Interest expense
526,000 618,000 583,000 987,000
Gain on extinguishment of debt, net
---0
Other income (expense), net
525,000 -2,939,000 -300,000 -2,084,500
Total other income (expense), net
3,401,000 -2,091,000 690,000 -1,058,000
Income (loss) from continuing operations before provision for income taxes
-6,531,000 -11,740,000 -8,794,000 -18,664,000
Provision for income taxes
165,000 274,000 234,000 122,000
Income (loss) from continuing operations
-6,696,000 -12,014,000 -9,028,000 -
Income (loss) from discontinued operations, net
-247,000 117,194,000 -2,953,000 -
Net income (loss)
-6,943,000 105,180,000 -11,981,000 -18,786,000
Paid-in-kind dividend on series c convertible preferred stock
2,000,000 2,000,000 2,000,000 2,000,000
Net income (loss) attributable to common stockholders
-8,943,000 103,180,000 -13,981,000 -20,786,000
Earnings per share, basic
-0.18 2.05 -0.28 -0.425
Earnings per share, diluted
-0.18 2.05 -0.28 -0.425
Weighted average number of shares outstanding, basic
50,125,268 50,257,112 49,947,012 -24,706,888.5
Weighted average number of shares outstanding, diluted
50,125,268 50,257,112 49,947,012 -24,706,888.5
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net income (loss)attributable to common...-$8,943,000 Paid-in-kind dividend onseries c convertible...$2,000,000 Net income (loss)-$6,943,000 Income (loss) fromdiscontinued operations, net-$247,000 Income (loss) fromcontinuing operations-$6,696,000 Other income(expense), net$525,000 Investment income$3,402,000 Product$19,975,000 Service$24,258,000 Provision for income taxes$165,000 Income (loss) fromcontinuing operations...-$6,531,000 Total other income(expense), net$3,401,000 Total revenue$44,233,000 Interest expense$526,000 Loss from operations-$9,932,000 Gross margin$21,325,000 Total cost of revenue$22,908,000 Total operating costsand expenses$31,257,000 Product$10,707,000 Service$12,201,000 Engineering and development$4,523,000 Selling, general andadministrative$26,734,000

Cryoport, Inc. (CYRX)

Cryoport, Inc. (CYRX)